Drugs in Development
All Data
Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE
Lead Product(s): PB101
Therapeutic Area: Oncology Product Name: PB101
Highest Development Status: Undisclosed Product Type: Large molecule
Partner/Sponsor/Collaborator: Panolos
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement September 17, 2020
Details:
Samsung Biologics will provide a full scope of its development services from cell line development, process development, to non-clinical and clinical material manufacturing for Panolos Bioscience's PB101, an Fc-fusion protein intended to treat solid tumors.
Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE
Lead Product(s): STT-003
Therapeutic Area: Oncology Product Name: Undisclosed
Highest Development Status: Undisclosed Product Type: Large molecule
Partner/Sponsor/Collaborator: STCube
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement March 02, 2020
Details:
Samsung Biologics will offer a wide range of services from cell line development, process development, manufacturing of non-clinical and clinical material, to IND submission for STCube.
Market Place
Active Pharmaceutical Ingredients
Finished Drug Formulations
Price
Excipients
Services
Marketplace
